Author: Ken Dropiewski

Surmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1

April 19, 2024 07:00 AM Eastern Daylight Time EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that second quarter of fiscal year 2024 financial results will be released before the market opens on Wednesday, […]

Avive Solutions Raises $56.5M in Growth Funding To Build Connected AED Network and Transform Cardiac Arrest Emergency Response in Communities Nationwide

$56.5M Equity Financing Led by Questa Capital, Laerdal Million Lives Fund, and Catalyst Health Ventures, with New Participation from RC Capital and Eckuity Capital Avive has rapidly built an expansive and diverse customer base, delivering its FDA approved and award-winning AED technology…

Karoo Health Launches Proprietary Technology Platform Kohere.ai to Supercharge Its Cardiac Value-based Care Model

AI-enriched platform transforms disparate data into actionable insights for care providers and partners, boosts patient engagement and access to care for improved outcomes at lower cost ALBUQUERQUE, N.M., April 18, 2024 /PRNewswire/ — Karoo Health, the only operational provider of…

AtriCure Announces Launch of the cryoSPHERE®+ Probe for Post-Operative Pain Management

MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that it has launched the cryoSPHERE®+ cryoablation probe, leveraging new insulation technology to reduce freeze times by 25% versus AtriCure’s legacy cryoSHPERE® device. The […]

Volta Medical Announces Presentations at Heart Rhythm Society 2024 in Boston, MA, USA

• Demonstration of Volta AF-Xplorer™ at Heart Rhythm Society (HRS) 2024, May 16-19 • Dr. Andrea Natale, a world recognized leader in the field of electrophysiology, to moderate Rhythm Theater MARSEILLE, France, April 18, 2024 (GLOBE NEWSWIRE) — Volta Medical, a pioneering health technology company developing artificial intelligence (AI) solutions to […]

AskBio receives FDA Fast Track Designation for AB-1002 investigational gene therapy program in congestive heart failure

Berlin, Germany, and Research Triangle Park, NC, USA, April 18, 2024 (GLOBE NEWSWIRE) — Not intended for UK Media   AB-1002 is being studied for the treatment of adults with non-ischemic cardiomyopathy and New York Heart Association (NYHA) Class III heart failure symptoms AskBio is currently enrolling patients in the Phase […]